Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant. NICE technology appraisal guidance 640
National Institute for Health and Care Excellence (NICE)
Record ID 32018011687
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/ta640
Year Published:
2020
URL for published report:
https://www.nice.org.uk/guidance/ta640
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England
MeSH Terms
- Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- Stem Cell Transplantation
- Vidarabine
- Antineoplastic Agents, Alkylating
- Busulfan
- Transplantation Conditioning
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.